Corline Biomedical AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Henrik Nittmar, was filed 17 Feb 2026.
Corline Biomedical AB: what insiders have been doing
Corline Biomedical AB is a Health Care company. Its directors and officers file their transactions with Finansinspektionen. In the past year (30 October 2025 to 30 October 2026), 3 filings came from 1 insider.
On the market, 1 insider bought (2 purchases totalling €35k) while 1 insider sold (1 sale totalling €9,436). The net balance comes to €25k on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The buyers include 1 chief executive. At €21k, the purchase published on 18 November 2025 by Henrik Nittmar is the largest of the period (0.051% of market cap).
The last purchase on record was published on 17 February 2026, which is 264 days ago. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. For comparison, MAR article 19 gives managers three business days to notify a trade.
Compared with its exchange (1,035 companies, median 9 filings), a count of 3 filings is below the norm. The full history, which starts in 2021, counts 17 purchases against 3 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 6,557 shares@ SEK 16.03370.023% mcap30.9% of flowAktieISIN SE0006887451FI:csv-2395d0453e46348ce835
- 10,000 shares@ SEK 14.540.032% mcap100.0% of flowAktieISIN SE0006887451FI:A003W101-1Canonical exit: 18 May 2026 (T+90)
- 13,000 shares@ SEK 17.800.051% mcap100.0% of flowAktieFI:A003T765-1Canonical exit: 16 Feb 2026 (T+90)
- 333,333 shares@ SEK 6.0096.0% of flowAktieISIN SE0006887451FI:csv-634e5cb005f16ed31315Canonical exit: 6 Feb 2025 (T+90)
- 333,333 shares@ SEK 6.00100.0% of flowAktieISIN SE0006887451FI:csv-13b1cdfb7c9eb3371500Canonical exit: 6 Feb 2025 (T+90)
- 66,666 shares@ SEK 6.0022.0% of flowAktieISIN SE0006887451FI:csv-47aa9fa9e8877356f055Canonical exit: 6 Feb 2025 (T+90)
- 85,963 shares@ SEK 0.8954.3% of flowTeckningsoptionFI:csv-d7934b9462ed2b6ae26cCanonical exit: 1 Sept 2024 (T+90)
- 100,000 shares@ SEK 0.89531.2% of flowTeckningsoptionISIN SE0006887451FI:csv-7191a7748d3bf0108a59Canonical exit: 1 Sept 2024 (T+90)
- 50,000 shares@ SEK 0.89524.6% of flowOptionISIN SE0006887451FI:csv-152a9d1024b0f72f93f5Canonical exit: 25 Aug 2024 (T+90)
- 100,000 shares@ SEK 0.895100.0% of flowTeckningsoptionISIN SE0006887451FI:csv-c009d40d678eb17375c4
- 50,000 shares@ SEK 2.38567.0% of flowTeckningsoptionISIN SE0015356944FI:csv-06c490f6fdb783af9b39Canonical exit: 2 Aug 2023 (T+90)
- 100,000 shares@ SEK 2.38596.4% of flowTeckningsoptionFI:csv-def23ebfccbf110d42e7Canonical exit: 2 Aug 2023 (T+90)
- 75,000 shares@ SEK 2.38562.8% of flowTeckningsoptionFI:csv-bdcbdffd9fa38c52d74cCanonical exit: 2 Aug 2023 (T+90)
- 75,218 shares@ SEK 2.38510.1% of flowTeckningsoptionFI:csv-13413002a9b8869fb467Canonical exit: 2 Aug 2023 (T+90)
- 75,218 shares@ SEK 1.1865.0% of flowTeckningsoptionFI:csv-128528deabc1d09725da
- 20,000 shares@ SEK 0.433.1% of flowTeckningsoptionISIN SE0015356944FI:csv-4c2d52c2a9b775f5e8bd
- 20,000 shares@ SEK 0.4315.0% of flowTeckningsoptionFI:csv-c7c2b737eb2782e39cfeCanonical exit: 7 Jan 2023 (T+90)
- 42,982 shares@ SEK 0.4311.1% of flowTeckningsoptionFI:csv-9d84cd4d8e4464e8afad
- 20,000 shares@ SEK 0.433.6% of flowTeckningsoptionFI:csv-18f225c57ea14da03e78Canonical exit: 7 Jan 2023 (T+90)
- 7 shares@ SEK 0.340.0% of flowTeckningsrätt/UniträttISIN SE0015356936FI:csv-c21e8caa03edf1bb298e
- 12,363 shares@ SEK 10.00100.0% of flowBTA (betald tecknad aktie)ISIN SE0015356944FI:csv-33a23ef801b22e295710Canonical exit: 22 Apr 2021 (T+90)
- 7,272 shares@ SEK 10.00100.0% of flowBTA (betald tecknad aktie)ISIN SE0015356944FI:csv-38001e3157f0c6f519f1Canonical exit: 22 Apr 2021 (T+90)
- 8 shares@ SEK 0.340.0% of flowTeckningsrätt/UniträttISIN SE0015356936FI:csv-ccf0a9151008dd04d7ea
- 746 shares@ SEK 10.00100.0% of flowBTA (betald tecknad aktie)ISIN SE0015356944FI:csv-76cb46d8aa24d92e6227
- 46,832 shares@ SEK 10.0051.3% of flowBTA (betald tecknad aktie)FI:csv-497ac4cb945ea3a7bc69Canonical exit: 22 Apr 2021 (T+90)
25 of 27 declarations
About Corline Biomedical AB
Corline Biomedical AB is a company focused on the development of biopharmaceutical products. It concentrates on innovative solutions for the treatment of serious diseases.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
